4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-006741
Options or other derivatives
- Director acquired 2,100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| FOLLMAN ROBERT J Director | 2016-08-10 | Grant or award · 5% Secured Convertible Note due December 2017 | +100,000 | 550,000 | I | ||
| FOLLMAN ROBERT J Director | 2016-08-10 | Grant or award · Common Stock Warrant | +2,000,000 | 11,000,000 | I | ||
Loading xslF345X03/s103900_form4-rjfollman.xml…